📅Offer Date: 25 Apr 2023 – 27 Apr 2023
Data sourced from BSE & NSE · Last updated
Mankind Pharma Limited IPO was subscribed 15.32x in total when bidding closed on 27 Apr 2023, with 49.16x in the QIB category, 3.80x in NII, 0.92x in retail. The issue ran from 25 Apr 2023 to 27 Apr 2023 at a price band of ₹1026.00–₹1080.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (0.92x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 80,11,769 | 39,38,58,564 | 49.16x |
| NIIs | 60,08,827 | 2,28,33,543 | 3.80x |
| SNIIs (<10L) | 20,02,942 | 28,24,148 | 1.41x |
| BNIIs (>10L) | 40,05,885 | 1,99,89,366 | 4.99x |
| Retail | 1,40,20,596 | 1,28,98,948 | 0.92x |
| Total | 2,80,41,192 | 42,95,91,061 | 15.32x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 865.27 | 42536.72 | 49.16x |
| NIIs | 648.95 | 2466.02 | 3.80x |
| Retail | 1514.22 | 1393.09 | 0.92x |
| Total | 3028.45 | 46395.83 | 15.32x |
Values derived from share count × issue price (₹1080.00)
Because Mankind Pharma Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.